These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11439336)

  • 1. Hepatocyte Growth Factor/scatter factor-induces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner.
    Crostella L; Lidder S; Williams R; Skouteris GG
    Oncogene; 2001 Jun; 20(28):3735-45. PubMed ID: 11439336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta-subunit of the hepatocyte growth factor/scatter factor (HGF/SF) receptor phosphorylates and associates with CrkII: expression of CrkII enhances HGF/SF-induced mitogenesis.
    Riordan SM; Lidder S; Williams R; Skouteris GG
    Biochem J; 2000 Sep; 350 Pt 3(Pt 3):925-32. PubMed ID: 10970810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
    Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
    Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains.
    Bardelli A; Maina F; Gout I; Fry MJ; Waterfield MD; Comoglio PM; Ponzetto C
    Oncogene; 1992 Oct; 7(10):1973-8. PubMed ID: 1328986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.
    Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K
    J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.
    Oneyama C; Nakano H; Sharma SV
    Oncogene; 2002 Mar; 21(13):2037-50. PubMed ID: 11960376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential phosphorylation of the docking protein Gab1 by c-Src and the hepatocyte growth factor receptor regulates different aspects of cell functions.
    Chan PC; Sudhakar JN; Lai CC; Chen HC
    Oncogene; 2010 Feb; 29(5):698-710. PubMed ID: 19881549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential requirement of Grb2 and PI3-kinase in HGF/SF-induced cell motility and tubulogenesis.
    Royal I; Fournier TM; Park M
    J Cell Physiol; 1997 Nov; 173(2):196-201. PubMed ID: 9365521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation.
    Selbach M; Moese S; Hurwitz R; Hauck CR; Meyer TF; Backert S
    EMBO J; 2003 Feb; 22(3):515-28. PubMed ID: 12554652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor.
    Komada M; Kitamura N
    Oncogene; 1993 Sep; 8(9):2381-90. PubMed ID: 7689722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho regulates the hepatocyte growth factor/scatter factor-stimulated cell motility of human oral squamous cell carcinoma cells.
    Kitajo H; Shibata T; Nagayasu H; Kawano T; Hamada J; Yamashita T; Arisue M
    Oncol Rep; 2003; 10(5):1351-6. PubMed ID: 12883706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.
    Fixman ED; Naujokas MA; Rodrigues GA; Moran MF; Park M
    Oncogene; 1995 Jan; 10(2):237-49. PubMed ID: 7838524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
    Zhang YW; Vande Woude GF
    J Cell Biochem; 2003 Feb; 88(2):408-17. PubMed ID: 12520544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM; Hartmann G; Naldini L; Comoglio PM; Sachs M; Fonatsch C; Rieder H; Birchmeier W
    EXS; 1993; 65():311-28. PubMed ID: 8380739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions.
    Lamorte L; Royal I; Naujokas M; Park M
    Mol Biol Cell; 2002 May; 13(5):1449-61. PubMed ID: 12006644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.
    Maulik G; Kijima T; Ma PC; Ghosh SK; Lin J; Shapiro GI; Schaefer E; Tibaldi E; Johnson BE; Salgia R
    Clin Cancer Res; 2002 Feb; 8(2):620-7. PubMed ID: 11839685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential.
    Bardelli A; Longati P; Gramaglia D; Stella MC; Comoglio PM
    Oncogene; 1997 Dec; 15(25):3103-11. PubMed ID: 9444958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.